These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 5494364)

  • 1. [Clinical studies on actebral in neurology].
    Devic M
    Rev Lyon Med; 1970 Jan; 19(2):59-64. PubMed ID: 5494364
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic indications of a psychotonic: Actebral].
    Pauly R; Maisondieu J
    Bord Med; 1970 Feb; 3(2):541-51. PubMed ID: 5425881
    [No Abstract]   [Full Text] [Related]  

  • 3. Steroids in neurology.
    Wiles CM
    Br J Hosp Med; 1982 Oct; 28(4):308, 313-6, 321-2. PubMed ID: 7139155
    [No Abstract]   [Full Text] [Related]  

  • 4. Advances in neurology.
    Tyler HR
    Practitioner; 1968 Oct; 201(204):591-7. PubMed ID: 4879610
    [No Abstract]   [Full Text] [Related]  

  • 5. [Naphthydrofuryl in neurology].
    Ahumada BH
    Prensa Med Argent; 1971 Jul; 58(21):1067-70. PubMed ID: 5096690
    [No Abstract]   [Full Text] [Related]  

  • 6. Cydandelate for cerebrovascular disease.
    Drug Ther Bull; 1968 Nov; 6(23):92. PubMed ID: 5697287
    [No Abstract]   [Full Text] [Related]  

  • 7. [School and family adjustment problems in children and LB 125].
    Durand CH
    Ann Pediatr (Paris); 1968 May; 15(5):411-3. PubMed ID: 5674599
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment with a brain tissue hydrolysate. Clinical observations and results of experimental studies].
    Harrer G; Sommer H
    Neurol Neurochir Pol; 1974; 8(5):737-43. PubMed ID: 4215047
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical evaluation of (-) eburnamonine in chronic cerebrovascular insufficiency].
    De Pergola E; Di Lorenzo L; De Pergola G
    G Clin Med; 1980 Aug; 61(8):628-42. PubMed ID: 7004986
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapeutic results in peripheral and cerebrovascular blood circulation disorders following the administration of Dusodril].
    Kaufmann J; Förster W
    Z Allgemeinmed; 1970 May; 46(13):688-9. PubMed ID: 5522940
    [No Abstract]   [Full Text] [Related]  

  • 11. [Value of Calgam in the treatment of cerebrovascular diseases].
    Wasilewski R; Kossowska W; Rubach K
    Pol Tyg Lek; 1971 Mar; 26(9):316-8. PubMed ID: 5550673
    [No Abstract]   [Full Text] [Related]  

  • 12. [Value of a new activator of cerebral metabolism, Cyprodemanol, in the field of geriatric psychiatry].
    Genevieve JM
    Encephale; 1970; 59(3):90-5. PubMed ID: 5422001
    [No Abstract]   [Full Text] [Related]  

  • 13. [Report on experiences with the complex treatment of cerebral and peripheral circulatory disorders].
    Basarab A
    Med Welt; 1973 Apr; 24(16):650-2. PubMed ID: 4756330
    [No Abstract]   [Full Text] [Related]  

  • 14. Key developments in neurology.
    Lindahl AJ; Scolding NJ
    Practitioner; 2004 Jul; 248(1660):490, 492-4, 497 passim. PubMed ID: 15255409
    [No Abstract]   [Full Text] [Related]  

  • 15. Preliminary observations on L-dopa in the treatment of Parkinson's disease.
    Jelsma F; Roth R; Ross P; Davis J
    J Ky Med Assoc; 1971 Apr; 69(4):265-9. PubMed ID: 5577419
    [No Abstract]   [Full Text] [Related]  

  • 16. The two faces of L-DOPA: benefits and adverse side effects in the treatment of Encephalitis lethargica, Parkinson's disease, multiple sclerosis and amyotrophic lateral sclerosis.
    Foster HD; Hoffer A
    Med Hypotheses; 2004; 62(2):177-81. PubMed ID: 14962622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duration of relaxation after intramuscular neurolysis with phenol.
    Halpern D; Meelhuysen FE
    JAMA; 1967 Jun; 200(13):1152-4. PubMed ID: 6071675
    [No Abstract]   [Full Text] [Related]  

  • 18. Vasodilators in prevention and treatment of ischemic stroke.
    Taylor JR
    J Iowa Med Soc; 1970 Apr; 60(4):258-61. PubMed ID: 5434836
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical and therapeutic considerations on a new benzodiazepine derivative].
    Passeri S; Bagnasco V; Corrente V
    Minerva Med; 1967 Nov; 58(94):4097-102. PubMed ID: 6075239
    [No Abstract]   [Full Text] [Related]  

  • 20. Botulinum A toxin in the treatment of neurogenic detrusor overactivity: a consolidated field of application.
    Giannantoni A; Mearini E; Del Zingaro M; Santaniello F; Porena M
    BJU Int; 2008 Jul; 102 Suppl 1():2-6. PubMed ID: 18665971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.